General Notices

• Pre-Application Webinar for RFA-CA-21-060, RFA-CA-21-061, and RFA-CA-21-062: "The NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers"
  (NOT-CA-22-019)
  National Cancer Institute
  

Notice of Changes to Funding Opportunities

• Notice of Early Expiration of PAR-19-078, Molecular and Genetic Characterization of Inborn Errors of Immunity (R01 Clinical Trial Not Allowed)"
  (NOT-AI-22-005)
  National Institute of Allergy and Infectious Diseases
  

• Notice of Early Expiration of PAR-19-079, Molecular and Genetic Characterization of Inborn Errors of Immunity (R21 Clinical Trial Not Allowed)"
  (NOT-AI-22-006)
  National Institute of Allergy and Infectious Diseases
  

• Notice of NIAMS' Participation in PA-18-935 "Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)"
  (NOT-AR-21-028)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  

• Notice of Clarification of Award Budget Instructions for Specific Aims in RFA-ES-21-007, Virtual Consortium for Translational/Transdisciplinary Environmental Research (ViCTER) (R01 Clinical Trial Optional)
  (NOT-ES-22-004)
  National Institute of Environmental Health Sciences
  

• Notice of Correction to Award Information for RFA-RM-22-006, " Expert-Driven Small Projects to Strengthen Gabriella Miller Kids First Discovery (R03 Clinical Trial Not Allowed)"
  (NOT-RM-22-005)
  Office of Strategic Coordination (Common Fund)
  

• Notice of Change to Participant Eligibility, Participant Costs and Other Attachments to Funding Opportunity Announcement PAR-21-339, Limited Competition: NCATS Clinical and Translational Science Award (CTSA) Program Research Education Grants Program (R25)
  (NOT-TR-22-010)
  National Center for Advancing Translational Sciences
  

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional)
  (NOT-DA-21-084)
  National Institute on Drug Abuse
  

• Notice of Intent to Publish a Funding Opportunity Announcement for NIDCD National Human Ear Resource Network (U24)
  (NOT-DC-22-006)
  National Institute on Deafness and Other Communication Disorders
  

Notices of Special Interest

• Notice of Special Interest (NOSI): Molecular and Genetic Characterization of Inborn Errors of Immunity
  (NOT-AI-21-082)
  National Institute of Allergy and Infectious Diseases
  

Funding Opportunities

• Drug Discovery For Nervous System Disorders (R01 Clinical Trials Not Allowed)
  (PAR-22-031)
  National Institute of Mental Health
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Drug Abuse
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Drug Discovery For Nervous System Disorders (R21 Clinical Trials Not Allowed)
  (PAR-22-032)
  National Institute of Mental Health
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Drug Abuse
  Application Receipt Date(s): January 07, 2025
  
  

• NIGMS National and Regional Resources (R24 - Clinical Trial Not Allowed)
  (PAR-22-065)
  National Institute of General Medical Sciences
  Application Receipt Date(s): June 14, 2024
  
  

• Resource Networks for Protein Polymorphisms in Alzheimers Disease and its Related Dementias (AD/ADRD) (U24 Clinical Trial Not Allowed)
  (RFA-AG-22-030)
  National Institute on Aging
  Application Receipt Date(s): January 10, 2022
  
  

• Conformance with the Egg Regulatory Program Standards (U2F) [Clinical Trial Not Allowed]
  (RFA-FD-22-006)
  Food and Drug Administration
  Application Receipt Date(s): January 31, 2022 by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
  
  

• Child Health Research Career Development Award (CHRCDA) Program (K12 Clinical Trial Not Allowed)
  (RFA-HD-23-010)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): March 30, 2022